Overview

Alvimopan Use in Polytraumatized Patients

Status:
Terminated

Trial end date:
2019-11-19

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of Alvimopan(12 mg) in recovery of bowel function in an emergency trauma setting without the pre-operative dosage in patients that will receive abdominal surgery.

Phase:

Phase 4

Details

Lead Sponsor:

University of Puerto Rico

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Alvimopan